King & Wood Mallesons (“KWM”) advised Greenland Holding Group (“Greenland”) on its successful completion of back-door listing by injecting assets of over RMB 66.7 billion into Shanghai Jinfeng Investment Co., Ltd. (“Jinfeng Investment”) in exchange for over 11.6 billion shares.  In this project, assets restructuring included two processes: replacement of assets, and purchase of assets by issuing shares. To-date, this is the largest non-financial corporate M&A deal in the China A-share market.

King & Wood Mallesons (KWM) has advised AAG Energy Holdings Limited (AAG Energy) on its successful red chip listing on the main board of the Stock Exchange of Hong Kong.(stock code: 02686). The shares have been offered globally, and are crowned the first stock to be offered by a Chinese Coal Bed Methane (CBM) commercial developer. In this project, a total number of761.4million shares have been issued globally with net proceeds of approximately HKD $1.923 billion after deduction of the underwriting commissions and other  expenses.

Norton Rose Fulbright has advised BOCI Asia on Sky Light Holdings Limited’s HK$676 million global offering and its initial public offering on the Main Board of the Hong Kong Stock Exchange.

BOCI Asia Limited was sole sponsor, sole global coordinator, sole bookrunner and sole lead manager.

Simpson Thacher recently represented Sony Corporation in connection with its offering of an aggregate of 92,000,000 million shares of common stock, which included an international offering to institutional investors outside of the United States pursuant to Regulation S and inside the United States in a manner exempt from registration under the U.S. Securities Act of 1933. The offering is expected to raise a total of approximately ¥300 billion, assuming the exercise in full of the overallotment options.

Paul Hastings has represented Morgan Stanley Asia Limited and CCB International Limited as the underwriters in Harmonicare Medical Holdings Limited’s (“Harmonicare Medical”) US$205 Million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.

Harmonicare Medical is the largest private obstetrics and gynecology specialty hospital group in China.

Dechert LLP advised Cellnovo, an innovative biotechnology company, on the success of its IPO in compartment C of the Euronext regulated market in Paris, raising €31.56 million through capital increase.

Ashurst Hong Kong acted for Nomura International (Hong Kong) Limited in the HK$140 million placement of new shares by HKSE-listed Golden Meditech Holdings Limited to Atlantis Investment Management (Hong Kong) Limited.  Nomura acted as the placing agent in the placement. Golden Meditech is a leading integrated-healthcare device and service operator in the PRC. Golden Meditech intends to apply the net proceeds from the placement for the acquisition of shares in NYSE-listed China Cord Blood Corporation by way of a general offer.

Shearman & Sterling has advised Citycon Oyj in connection with its approximately €600 million rights issue.

Citycon intends to use the proceeds from the rights issue for the financing in part of the €1.47 billion acquisition of the Norwegian shopping center company Sektor Gruppen AS and the related early redemption by Sektor of its outstanding bonds.

Stibbe advised Kempen & Co, Degroof Corporate Finance, Bank Degroof and ING (together the joint global coordinators and joint bookrunners) in the private offering by NSI N.V. of 35% of its shares in Intervest Offices & Warehouses NV to a broad group of institutional and qualified investors.

Sampension, Friheden Invest and a group of current shareholders invest SEK 250 million in ecommerce company BZT Fashion AB, which owns and operates Boozt.com. The capital injection strengthens theehandel company’s growth opportunities in the attractive e-commerce market for adult and children’s clothes in the mid and premium segments.